Later studies showed that IL-17 induced a wide range of angiogenic mediators (Numasaki et al., 2004; Takahashi et al., 2005; Honorati et al., 2006), including vascular endothelial growth factor (VGEF), that markedly promotes inflammation and tumor angiogenesis. The gene discussed is IL17A; the disease is neoplasm.